December 19, 2016
Adocia/Lilly successfully complete insulin pump study
Adocia and Eli Lilly have completed an insulin pump study under the Adocia-Lilly partnership evaluating BioChaperone Lispro, an ultra-rapid formulation…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
December 19, 2016
Innate Pharma picks AstraZeneca’s oncology specialist Mondher Mahjoubi
Innate Pharma has announced key leadership team and Board changes which will take effect on December 30th, 2016.
December 19, 2016
Veloxis increases capital by 1,5M new shares
Danish pharmaceutical company Veloxis Pharmaceuticals A/S, has increased its capital by 1,500,000 new shares. The company said on Monday that…
December 19, 2016
Chinese AceCGT bags distribution deal with Belgian MDxHealth for prostate cancer assay in Hong Kong and Macao
MDxHealth has signed a distribution agreement with AceCGT Life Science Limited for their SelectMDx for Prostate Cancer assay in Hong Kong…
December 19, 2016
ADA updates recommendation for Lilly’s type 2 diabetes drug
The American Diabetes Association (ADA) has included new recommendation about the use of Jardiance tablets for type 2 diabetes patients…
December 19, 2016
Janssen asks FDA’s permission to treat adolescent plaque psoriasis patients with Solara
Janssen Biotech is looking to expand the usage of its prescription drug Stelara, as it has asked the U.S. Food…
December 16, 2016
Lilly/Incyte’s rheumatoid arthritis drug gets CHMP’s recommendation for EMA’s approval
Eli Lilly and Incyte Corporation have gotten positive opinion from European Medicines Agency’s (EMA) Committee for Medicinal Products for Human…
December 16, 2016
Mylan Launches generic for EpiPen adrenaline injection, fights rising US drug prices
Mylan is launching its generic for EpiPen adrenaline injection at a wholesale acquisition cost (WAC) of $300 per epinephrine injection. As…
December 16, 2016
Novartis’s epilepsy drug gets CHMP’s positive opinion
Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for…
December 16, 2016
ABIVAX welcomes Didier Blondel as CFO
ABIVAX has appointed Didier Blondel as Chief Financial Officer, effective January 2nd, 2017.